Dr. Kevin Jao
Claim this profileHopital Du Sacre Coeur de Montreal
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
4 drugs studied
Area of expertise
1Lung Cancer
EGFR positive
Stage IV
Stage III
2Non-Small Cell Lung Cancer
EGFR positive
Stage IV
Stage III
Affiliated Hospitals
Hopital Du Sacre Coeur De Montreal
More about Kevin Jao
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Kevin Jao has experience with
- Carboplatin
- Cisplatin
- Pemetrexed
- TAK-788
Breakdown of trials Kevin Jao has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Jao specialize in?
Kevin Jao focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved EGFR positive patients, or patients who are Stage IV.
Is Kevin Jao currently recruiting for clinical trials?
No, Kevin Jao is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Kevin Jao has studied deeply?
Yes, Kevin Jao has studied treatments such as Carboplatin, Cisplatin, Pemetrexed.
What is the best way to schedule an appointment with Kevin Jao?
Apply for one of the trials that Kevin Jao is conducting.
What is the office address of Kevin Jao?
The office of Kevin Jao is located at: Hopital Du Sacre Coeur de Montreal, Montreal, Quebec H4J 1C5 Canada. This is the address for their practice at the Hopital Du Sacre Coeur de Montreal.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.